3-Bromo-5-cyanobenzotrifluoride | CAS:691877-03-9

We serve 3-Bromo-5-cyanobenzotrifluoride CAS:691877-03-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
3-Bromo-5-cyanobenzotrifluoride

Chemical Name:3-Bromo-5-cyanobenzotrifluoride
CAS.NO:691877-03-9
Synonyms:3-Bromo-5-cyanobenzotrifluoride
3-bromo-5-trifluoromethyl-benzonitrile
5-bromo-3-(trifluoromethyl)benzenecarbonitrile
3-Bromo-5-(trifluoromethyl)benzonitrile
 
Physical and Chemical Properties:
Density 1.7±0.1 g/cm3
Boiling Point 216.0±35.0 °C at 760 mmHg
Molecular Formula C8H3BrF3N
Molecular Weight 250.015
Flash Point 84.5±25.9 °C
Vapour Pressure 0.1±0.4 mmHg at 25°C
Index of Refraction 1.517
 
Specification:
Appearance:Light yellow liquid
Assay:≥98.0%
Moisture:≤0.3%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Organic synthesis.



Contact us for information like 3-Bromo-5-cyanobenzotrifluoride chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-Bromo-5-(trifluoromethyl)benzonitrile physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,5-bromo-3-(trifluoromethyl)benzenecarbonitrile Use and application,3-Bromo-5-(trifluoromethyl)benzonitrile technical grade,usp/ep/jp grade.


Related News: All of China’s provinces and territories have now been touched by the outbreak.2-Fluoro-6-nitrobenzoic acid manufacturer Another prominent coronavirus to emerge since the turn of the century is Middle East respiratory syndrome (MERS), which was first identified in Saudi Arabia in 2012 and killed more than 800 people.4'-Methyl-2-cyanobiphenyl supplier Another prominent coronavirus to emerge since the turn of the century is Middle East respiratory syndrome (MERS), which was first identified in Saudi Arabia in 2012 and killed more than 800 people.DL-Norvaline vendor The risk to the general public remains low. And we continue to be confident we are in a good position to respond to this developing situation.”An effective treatment for Alzheimer’s, which is estimated in 60%-70% of around 50 million dementia cases worldwide, could become one of the best-selling drugs globally.